Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Role of Toxoplasma gondii Chloroquine Resistance Transporter in Bradyzoite Viability and Digestive Vacuole Maintenance.

Kannan G, Di Cristina M, Schultz AJ, Huynh MH, Wang F, Schultz TL, Lunghi M, Coppens I, Carruthers VB.

MBio. 2019 Aug 6;10(4). pii: e01324-19. doi: 10.1128/mBio.01324-19.

2.

Phosphatidic acid governs natural egress in Toxoplasma gondii via a guanylate cyclase receptor platform.

Bisio H, Lunghi M, Brochet M, Soldati-Favre D.

Nat Microbiol. 2019 Mar;4(3):420-428. doi: 10.1038/s41564-018-0339-8. Epub 2019 Feb 11.

PMID:
30742070
3.

The neural correlates of orienting to walking direction in 6-month-old infants: An ERP study.

Lunghi M, Piccardi ES, Richards JE, Simion F.

Dev Sci. 2019 Feb 11:e12811. doi: 10.1111/desc.12811. [Epub ahead of print]

PMID:
30740853
4.

A mental number line in human newborns.

Di Giorgio E, Lunghi M, Rugani R, Regolin L, Dalla Barba B, Vallortigara G, Simion F.

Dev Sci. 2019 Jan 24:e12801. doi: 10.1111/desc.12801. [Epub ahead of print]

PMID:
30676679
5.

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers.

Barcellini W, Zaninoni A, Fattizzo B, Giannotta JA, Lunghi M, Ferrari A, Leporace AP, Maschio N, Scaramucci L, Cantoni S, Chiurazzi F, Consonni D, Rossi G, De Fabritiis P, Gaidano G, Zanella A, Cortelezzi A.

Am J Hematol. 2018 Sep;93(9):E243-E246. doi: 10.1002/ajh.25212. Epub 2018 Aug 25. No abstract available.

PMID:
29981267
6.

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Spagnoli A, Voso MT, Fianchi L, Papayannidis C, Gaidano GL, Breccia M, Musto P, De Bellis E, Del Principe MI, Lunghi M, Lessi F, Martinelli G, Venditti A.

Ann Hematol. 2018 Oct;97(10):1767-1774. doi: 10.1007/s00277-018-3374-x. Epub 2018 Jun 10.

PMID:
29947973
7.

Newborns are sensitive to the correspondence between auditory pitch and visuospatial elevation.

Walker P, Bremner JG, Lunghi M, Dolscheid S, D Barba B, Simion F.

Dev Psychobiol. 2018 Mar;60(2):216-223. doi: 10.1002/dev.21603. Epub 2018 Jan 22.

PMID:
29355921
8.

Toxoplasma-induced changes in host risk behaviour are independent of parasite-derived AaaH2 tyrosine hydroxylase.

Afonso C, Paixão VB, Klaus A, Lunghi M, Piro F, Emiliani C, Di Cristina M, Costa RM.

Sci Rep. 2017 Oct 23;7(1):13822. doi: 10.1038/s41598-017-13229-y.

9.

Cervical mass as the first clinical manifestation of unsuspected metastatic seminoma.

Ferri E, Pedruzzi B, Gasparin P, Lunghi M.

Auris Nasus Larynx. 2018 Jun;45(3):626-629. doi: 10.1016/j.anl.2017.07.015. Epub 2017 Aug 12.

PMID:
28807530
10.

Toxoplasma depends on lysosomal consumption of autophagosomes for persistent infection.

Di Cristina M, Dou Z, Lunghi M, Kannan G, Huynh MH, McGovern OL, Schultz TL, Schultz AJ, Miller AJ, Hayes BM, van der Linden W, Emiliani C, Bogyo M, Besteiro S, Coppens I, Carruthers VB.

Nat Microbiol. 2017 Jun 19;2:17096. doi: 10.1038/nmicrobiol.2017.96.

11.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Santini V, Allione B, Zini G, Gioia D, Lunghi M, Poloni A, Cilloni D, Sanna A, Masiera E, Ceccarelli M, Abdel-Wahab O, Terenzi A, Angelucci E, Finelli C, Onida F, Pelizzari A, Ferrero D, Saglio G, Figueroa M, Levis A.

Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.

12.

Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.

Messa E, Biale L, Castiglione A, Lunghi M, Bonferroni M, Salvi F, Allione B, Ferrero D, Calabrese C, De Gobbi M, Nicoli P, Gioia D, Levis A, Saglio G, Cilloni D.

Leuk Lymphoma. 2017 Nov;58(11):2752-2754. doi: 10.1080/10428194.2017.1312385. Epub 2017 May 9. No abstract available.

13.

Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

Boggio E, Gigliotti CL, Rossi D, Toffoletti E, Cappellano G, Clemente N, Puglisi S, Lunghi M, Cerri M, Vianelli N, Cantoni S, Tieghi A, Beggiato E, Gaidano G, Comi C, Chiocchetti A, Fanin R, Dianzani U, Zaja F.

Br J Haematol. 2017 Jan;176(2):258-267. doi: 10.1111/bjh.14248. Epub 2016 Jul 8.

PMID:
27391055
14.

The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer's Disease Pathogenesis.

Moncini S, Lunghi M, Valmadre A, Grasso M, Del Vescovo V, Riva P, Denti MA, Venturin M.

Mol Neurobiol. 2017 Aug;54(6):4329-4342. doi: 10.1007/s12035-016-0002-4. Epub 2016 Jun 24.

15.

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.

Gugliotta G, Castagnetti F, Breccia M, Gozzini A, Usala E, Carella AM, Rege-Cambrin G, Martino B, Abruzzese E, Albano F, Stagno F, Luciano L, D'Adda M, Bocchia M, Cavazzini F, Tiribelli M, Lunghi M, Pia Falcone A, Musolino C, Levato L, Venturi C, Soverini S, Cavo M, Alimena G, Pane F, Martinelli G, Saglio G, Rosti G, Baccarani M; GIMEMA CML Working Party.

Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

16.

Visual cues of motion that trigger animacy perception at birth: the case of self-propulsion.

Di Giorgio E, Lunghi M, Simion F, Vallortigara G.

Dev Sci. 2017 Jul;20(4). doi: 10.1111/desc.12394. Epub 2016 Feb 21.

PMID:
26898995
17.

Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.

Gyan E, Andrieu V, Sanna A, Caille A, Schemenau J, Sudaka I, Siguret V, Malet M, Park S, Bordessoule D, Mairesse J, Gelsi-Boyer V, Cheze S, Beyne-Rauzy O, Sébert M, Sapena R, Zerazhi H, Legros L, Guerci-Bresler A, Amé SN, Germing U, Santini V, Salvi F, Gioia D, Lunghi M, Dreyfus F, Fenaux P; Groupe Francophone des Myélodysplasies, Fondazione Italiana per le Sindromi Mielodisplastiche (FISMonlus), and Düsseldorf MDS Registry.

Br J Haematol. 2016 Dec;175(5):975-979. doi: 10.1111/bjh.13902. Epub 2016 Jan 15. No abstract available.

PMID:
26773632
18.

Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability.

Moncini S, Castronovo P, Murgia A, Russo S, Bedeschi MF, Lunghi M, Selicorni A, Bonati MT, Riva P, Venturin M.

J Hum Genet. 2016 Apr;61(4):283-93. doi: 10.1038/jhg.2015.144. Epub 2015 Dec 10.

PMID:
26657932
19.

Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite Interface.

Hammoudi PM, Jacot D, Mueller C, Di Cristina M, Dogga SK, Marq JB, Romano J, Tosetti N, Dubrot J, Emre Y, Lunghi M, Coppens I, Yamamoto M, Sojka D, Pino P, Soldati-Favre D.

PLoS Pathog. 2015 Oct 16;11(10):e1005211. doi: 10.1371/journal.ppat.1005211. eCollection 2015 Oct.

20.

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment.

Russo D, Malagola M, Skert C, Cancelli V, Turri D, Pregno P, Bergamaschi M, Fogli M, Testoni N, De Vivo A, Castagnetti F, Pungolino E, Stagno F, Breccia M, Martino B, Intermesoli T, Cambrin GR, Nicolini G, Abruzzese E, Tiribelli M, Bigazzi C, Usala E, Russo S, Russo-Rossi A, Lunghi M, Bocchia M, D'Emilio A, Santini V, Girasoli M, Lorenzo RD, Bernardi S, Palma AD, Cesana BM, Soverini S, Martinelli G, Rosti G, Baccarani M.

Blood Cancer J. 2015 Sep 18;5:e347. doi: 10.1038/bcj.2015.75.

21.

Alternative splicing mechanisms orchestrating post-transcriptional gene expression: intron retention and the intron-rich genome of apicomplexan parasites.

Lunghi M, Spano F, Magini A, Emiliani C, Carruthers VB, Di Cristina M.

Curr Genet. 2016 Feb;62(1):31-8. doi: 10.1007/s00294-015-0506-x. Epub 2015 Jul 21.

PMID:
26194054
22.

Walking direction triggers visuo-spatial orienting in 6-month-old infants and adults: An eye tracking study.

Bardi L, Di Giorgio E, Lunghi M, Troje NF, Simion F.

Cognition. 2015 Aug;141:112-20. doi: 10.1016/j.cognition.2015.04.014. Epub 2015 May 14.

PMID:
25978184
23.

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.

Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol JB, Selimoglu-Buet D, Masala E, Allione B, Gioia D, Poloni A, Lunghi M, Solary E, Abdel-Wahab O, Santini V, Figueroa ME.

J Clin Invest. 2015 May;125(5):1857-72. doi: 10.1172/JCI78752. Epub 2015 Mar 30.

24.

Expression of the glycolytic enzymes enolase and lactate dehydrogenase during the early phase of Toxoplasma differentiation is regulated by an intron retention mechanism.

Lunghi M, Galizi R, Magini A, Carruthers VB, Di Cristina M.

Mol Microbiol. 2015 Jun;96(6):1159-75. doi: 10.1111/mmi.12999. Epub 2015 Apr 11.

25.

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.

Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, Lunghi M, Tassinari C, Alfinito F, Ferrari A, Leporace AP, Niscola P, Carpenedo M, Boschetti C, Revelli N, Villa MA, Consonni D, Scaramucci L, De Fabritiis P, Tagariello G, Gaidano G, Rodeghiero F, Cortelezzi A, Zanella A.

Blood. 2014 Nov 6;124(19):2930-6. doi: 10.1182/blood-2014-06-583021. Epub 2014 Sep 16.

26.

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.

Ruggeri M, Tosetto A, Palandri F, Polverelli N, Mazzucconi MG, Santoro C, Gaidano G, Lunghi M, Zaja F, De Stefano V, Sartori R, Fazi P, Rodeghiero F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study ITP0311.

J Thromb Haemost. 2014 Aug;12(8):1266-73. doi: 10.1111/jth.12636. Epub 2014 Jul 16.

27.

hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3'-UTR and oppositely regulate its expression.

Zuccotti P, Colombrita C, Moncini S, Barbieri A, Lunghi M, Gelfi C, De Palma S, Nicolin A, Ratti A, Venturin M, Riva P.

Biochim Biophys Acta. 2014 Jun;1839(6):506-16. doi: 10.1016/j.bbagrm.2014.04.018. Epub 2014 May 2.

PMID:
24792867
28.

Harmonic scalpel versus conventional haemostasis in neck dissection: a prospective randomized study.

Ferri E, Armato E, Spinato G, Lunghi M, Tirelli G, Spinato R.

Int J Surg Oncol. 2013;2013:369345. doi: 10.1155/2013/369345. Epub 2013 Dec 22.

29.

Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.

Ottone T, Hasan SK, Voso MT, Ledda A, Montefusco E, Fenu S, Pagoni M, Hubmann M, Lunghi M, Platzbecker U, Lo-Coco F.

Am J Hematol. 2014 Mar;89(3):346-7. doi: 10.1002/ajh.23646. No abstract available.

30.

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.

Malagola M, Breccia M, Skert C, Cancelli V, Soverini S, Iacobucci I, Cattina F, Liberati AM, Tiribelli M, Annunziata M, Trabacchi E, De Vivo A, Castagnetti F, Martinelli G, Fogli M, Stagno F, Pica G, Iurlo A, Pregno P, Abruzzese E, Pardini S, Bocchia M, Russo S, Pierri I, Lunghi M, Barulli S, Merante S, Mandelli F, Alimena G, Rosti G, Baccarani M, Russo D.

Am J Hematol. 2014 Feb;89(2):119-24. doi: 10.1002/ajh.23593.

31.

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

Voso MT, Breccia M, Lunghi M, Poloni A, Niscola P, Finelli C, Bari A, Musto P, Zambello R, Fianchi L, Alimena G, Leone G.

Eur J Haematol. 2013 Apr;90(4):345-8. doi: 10.1111/ejh.12079. Epub 2013 Feb 28.

PMID:
23336938
32.

Cardiovascular events and intensity of treatment in polycythemia vera.

Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T; CYTO-PV Collaborative Group.

N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8.

33.

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

Breccia M, Fianchi L, Lunghi M, Gaidano G, Levis A, Finelli C, Santini V, Musto P, Mansueto G, Oliva EN, Leoni P, Spiriti MA, Hohaus S, Leone G, Alimena G, Voso MT.

Leuk Lymphoma. 2013 Aug;54(8):1786-7. doi: 10.3109/10428194.2012.749406. Epub 2012 Dec 10. No abstract available.

PMID:
23151268
34.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, Lunghi M, Pica G, Onida F, Cattaneo C, Piccaluga PP, Di Bona E, Todisco E, Musto P, Spadea A, D'Arco A, Pileri S, Leone G, Amadori S, Facchetti F; GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell'Adulto, Acute Leukemia Working Party).

Haematologica. 2013 Feb;98(2):239-46. doi: 10.3324/haematol.2012.072645. Epub 2012 Oct 12.

35.

Outcome of therapy-related myeloid neoplasms treated with azacitidine.

Fianchi L, Criscuolo M, Lunghi M, Gaidano G, Breccia M, Levis A, Finelli C, Santini V, Musto P, Oliva EN, Leoni P, Aloe Spiriti A, D'Alò F, Hohaus S, Pagano L, Leone G, Voso MT.

J Hematol Oncol. 2012 Aug 1;5:44. doi: 10.1186/1756-8722-5-44.

36.

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

Lobetti-Bodoni C, Ferrero D, Genuardi E, Passera R, Bernocco E, Sia D, Grignani G, Crisà E, Monitillo L, Rocci A, Drandi D, Giai V, Zanni M, Boi M, Isaia G, Barbero D, Lunghi M, Abruzzese E, Radaelli F, Pini M, Pregno P, Carlo-Stella C, Gaidano G, Boccadoro M, Ladetto M.

Mech Ageing Dev. 2012 Jul;133(7):479-88. doi: 10.1016/j.mad.2012.05.007. Epub 2012 Jun 9.

PMID:
22687638
37.

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).

Amadori S, Stasi R, Martelli AM, Venditti A, Meloni G, Pane F, Martinelli G, Lunghi M, Pagano L, Cilloni D, Rossetti E, Di Raimondo F, Fozza C, Annino L, Chiarini F, Ricci F, Ammatuna E, La Sala E, Fazi P, Vignetti M.

Br J Haematol. 2012 Jan;156(2):205-12. doi: 10.1111/j.1365-2141.2011.08940.x. Epub 2011 Nov 15.

PMID:
22082314
38.

Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.

Gugliotta L, Tieghi A, Tortorella G, Scalzulli PR, Ciancia R, Lunghi M, Cacciola E, Cacciola R, Candoni A, Crugnola M, Codeluppi K, Usala E, Specchia G, Martinelli V, Palmieri F, Pierri I, Liberati AM, Iurlo A, Grossi A, Vannucchi AM, Vianelli N, Mazzucconi MG.

Leuk Res. 2011 Dec;35(12):1557-63. doi: 10.1016/j.leukres.2011.06.030. Epub 2011 Jul 20.

PMID:
21764130
39.

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program.

Maurillo L, Venditti A, Spagnoli A, Gaidano G, Ferrero D, Oliva E, Lunghi M, D'Arco AM, Levis A, Pastore D, Di Renzo N, Santagostino A, Pavone V, Buccisano F, Musto P.

Cancer. 2012 Feb 15;118(4):1014-22. doi: 10.1002/cncr.26354. Epub 2011 Jul 14.

40.

Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program.

Musto P, Maurillo L, Spagnoli A, Gozzini A, Rivellini F, Lunghi M, Villani O, Aloe-Spiriti MA, Venditti A, Santini V; Ad Hoc Italian Cooperative Study Group on Azacitidine in Myelodysplastic Syndromes Acute Leukemias.

Cancer. 2010 Mar 15;116(6):1485-94. doi: 10.1002/cncr.24894.

41.

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.

Lunghi M, Casorzo L, De Paoli L, Riccomagno P, Rossi D, Gaidano G.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):89-92. doi: 10.1016/j.cancergencyto.2009.07.003. Review.

PMID:
19963141
42.

Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia.

Lunghi M, Riccomagno P, De Paoli L, Vendramin C, Conconi A, Gaidano G, Rossi D.

Am J Hematol. 2009 Oct;84(10):697-8. doi: 10.1002/ajh.21494. No abstract available.

43.

Surgical training in libya: the way forward.

Arifi A, Zaidan B, Mitiek M, Lunghi M.

Libyan J Med. 2009 Jun 1;4(2):86-8. doi: 10.4176/090318.

44.

Advanced mast cell disease: an Italian Hematological Multicenter experience.

Pagano L, Valentini CG, Caira M, Rondoni M, Van Lint MT, Candoni A, Allione B, Cattaneo C, Marbello L, Caramatti C, Pogliani EM, Iannitto E, Giona F, Ferrara F, Invernizzi R, Fanci R, Lunghi M, Fianchi L, Sanpaolo G, Stefani PM, Pulsoni A, Martinelli G, Leone G, Musto P.

Int J Hematol. 2008 Dec;88(5):483-488. doi: 10.1007/s12185-008-0166-4. Epub 2008 Nov 26.

PMID:
19034614
45.

Autoimmune thrombocytopenia (ITP) during pregnancy in a woman that underwent a splenectomy during childhood.

Paternoster DM, Bertolino M, Garofalo G, Merati E, Lunghi M, Surico N.

Minerva Ginecol. 2008 Dec;60(6):555-6. No abstract available.

PMID:
18981983
46.

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.

Rossi D, Cerri M, Capello D, Deambrogi C, Rossi FM, Zucchetto A, De Paoli L, Cresta S, Rasi S, Spina V, Franceschetti S, Lunghi M, Vendramin C, Bomben R, Ramponi A, Monga G, Conconi A, Magnani C, Gattei V, Gaidano G.

Br J Haematol. 2008 Jun;142(2):202-15. doi: 10.1111/j.1365-2141.2008.07166.x. Epub 2008 May 19.

PMID:
18492108
47.

Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.

Capello D, Deambrogi C, Rossi D, Lischetti T, Piranda D, Cerri M, Spina V, Rasi S, Gaidano G, Lunghi M.

Br J Haematol. 2008 May;141(4):504-11. doi: 10.1111/j.1365-2141.2008.07072.x. Epub 2008 Mar 3.

PMID:
18318760
48.

JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia.

Rossi D, Cresta S, Destro T, Vendramin C, Bocchetta S, De Paoli L, Cerri M, Lunghi M, Gaidano G.

Br J Haematol. 2007 Sep;138(6):813-4. Epub 2007 Jul 23. No abstract available.

PMID:
17645778
49.

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection.

Rossi D, Franceschetti S, Capello D, De Paoli L, Lunghi M, Conconi A, Gaidano G.

Am J Hematol. 2007 Dec;82(12):1103-5.

50.

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.

Rossi D, De Paoli L, Franceschetti S, Capello D, Vendramin C, Lunghi M, Conconi A, Magnani C, Gaidano G.

Br J Haematol. 2007 Jul;138(2):249-52. Epub 2007 May 29.

PMID:
17535272

Supplemental Content

Loading ...
Support Center